- Home
- TCBK vs TSHA Comparison
TCBK vs TSHA Comparison
Compare TCBK & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBK
- TSHA
- Stock Information
- Founded
- TCBK 1975
- TSHA 2019
- Country
- TCBK United States
- TSHA United States
- Employees
- TCBK N/A
- TSHA N/A
- Industry
- TCBK Major Banks
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- TCBK Finance
- TSHA Health Care
- Exchange
- TCBK Nasdaq
- TSHA Nasdaq
- Market Cap
- TCBK 1.4B
- TSHA 1.4B
- IPO Year
- TCBK N/A
- TSHA 2020
- Fundamental
- Price
- TCBK $44.06
- TSHA $5.01
- Analyst Decision
- TCBK Buy
- TSHA Strong Buy
- Analyst Count
- TCBK 5
- TSHA 9
- Target Price
- TCBK $48.60
- TSHA $10.00
- AVG Volume (30 Days)
- TCBK 79.9K
- TSHA 11.4M
- Earning Date
- TCBK 10-23-2025
- TSHA 11-04-2025
- Dividend Yield
- TCBK 3.29%
- TSHA N/A
- EPS Growth
- TCBK 5.66
- TSHA N/A
- EPS
- TCBK 3.55
- TSHA N/A
- Revenue
- TCBK $399,268,000.00
- TSHA $8,098,000.00
- Revenue This Year
- TCBK $9.45
- TSHA N/A
- Revenue Next Year
- TCBK $5.81
- TSHA N/A
- P/E Ratio
- TCBK $12.47
- TSHA N/A
- Revenue Growth
- TCBK 3.12
- TSHA N/A
- 52 Week Low
- TCBK $35.20
- TSHA $1.05
- 52 Week High
- TCBK $51.06
- TSHA $5.51
- Technical
- Relative Strength Index (RSI)
- TCBK 54.89
- TSHA 59.93
- Support Level
- TCBK $43.35
- TSHA $4.70
- Resistance Level
- TCBK $44.34
- TSHA $5.08
- Average True Range (ATR)
- TCBK 1.09
- TSHA 0.35
- MACD
- TCBK 0.23
- TSHA -0.07
- Stochastic Oscillator
- TCBK 93.46
- TSHA 49.16
About TCBK TriCo Bancshares
TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.